Clinical Trials Logo

Clinical Trial Summary

This study will:

Evaluate the in vivo histological and molecular effects of treatment with eMatrixCO2 and to determine the dynamics of their development over time following treatment.

Determine the safety and efficacy of treatment with eMatrixCO2 for use in Aesthetic dermatological procedures requiring the ablation, vaporization, excision, incision, or coagulation of soft tissue.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00992277
Study type Interventional
Source Syneron Medical
Contact
Status Completed
Phase Phase 2/Phase 3
Start date October 2009

See also
  Status Clinical Trial Phase
Recruiting NCT06142578 - Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices N/A
Not yet recruiting NCT06142643 - Safety and Effectiveness Clinical Evaluation of Injectable Medical Devices Viscol N/A